Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
88,000
Employees88,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
88,000
Employees88,000

PFE Key Statistics

Market cap
147.46B
Market cap147.46B
Price-Earnings ratio
34.98
Price-Earnings ratio34.98
Dividend yield
6.42%
Dividend yield6.42%
Average volume
50.32M
Average volume50.32M
High today
$25.90
High today$25.90
Low today
$25.86
Low today$25.86
Open price
$26.69
Open price$26.69
Volume
106.91K
Volume106.91K
52 Week high
$31.54
52 Week high$31.54
52 Week low
$25.20
52 Week low$25.20

PFE News

TipRanks 12h
Wolfe starts Pfizer at Underperform, notes underperformance versus peers

Wolfe Research initiated coverage of Pfizer (PFE) with an Underperform rating and $25 price target While it can be challenging to move the needle on large pharm...

Investor's Business Daily 19h
Is Pfizer Stock A Sell After Covid Products Drive Third-Quarter Upside?

Pfizer (PFE) stock tumbled after its third-quarter beat stemmed almost entirely from an unpredictable source: its Covid treatment Paxlovid. Sales of Covid trea...

Is Pfizer Stock A Sell After Covid Products Drive Third-Quarter Upside?
Benzinga 1d
The Oncology Bet Is Already Paying Off For Pfizer

With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc PFE reported it...

The Oncology Bet Is Already Paying Off For Pfizer

Analyst ratings

52%

of 27 ratings
Buy
44.4%
Hold
51.9%
Sell
3.7%

More PFE News

Simply Wall St 2d
Some Investors May Be Willing To Look Past Pfizer's Soft Earnings

Soft earnings didn't appear to concern Pfizer Inc.'s ( ) shareholders over the last week. We did some digging, and we believe the earnings are stronger than the...

Some Investors May Be Willing To Look Past Pfizer's Soft Earnings
Seeking Alpha 3d
Pfizer reportedly eyeing sale of hospital drugs unit

Pfizer (NYSE:PFE) has hired Goldman Sachs to gauge initial buyer interest as part of an attempt to sell its hospital drugs unit, Pfizer Hospital, valued potenti...

Pfizer reportedly eyeing sale of hospital drugs unit
TipRanks 3d
Pfizer exploring sale of hospital drugs unit, Reuters reports

Pfizer (PFE) is exploring the sale of its hospital drugs unit, now called Pfizer Hospital, which was formed after Pfizer bought Hospira for about $17B in 2015,...

TipRanks 7d
Pfizer Plans to Invest $1B in China

As companies begin considering moving their manufacturing operations outside of China in order to avoid Tariffs that will likely be imposed by President-Elect T...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.